Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldbaum

Showing results (511-520 of 533) with videos related to

Pageof 54
Sort By:
Mbio|February 14, 2023
A Fijivirus Major Viroplasm Protein Shows RNA-Stimulated ATPase Activity by Adopting Pentameric and Hexameric Assemblies of DimersGabriela Llauger, Roberto Melero, Demián Monti, et al.
BMC Medical Education|October 12, 2018
The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countriesGoonaseelan Pillai, Kelly Chibale, Edwin C Constable, et al.
Translational Vision Science & Technology|August 21, 2020
Effects of Study Population, Labeling and Training on Glaucoma Detection Using Deep Learning AlgorithmsMark Christopher, Kenichi Nakahara, Christopher Bowd, et al.
Vaccine|December 26, 2006
Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccineEdda Sciutto, Gabriela Rosas, Marisela Hernández, et al.
Veterinary Immunology and Immunopathology|September 10, 2025
Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in ramsMaría Celeste Moran, Agostina Tammone Santos, Paula Dominguez, et al.
Journal for Immunotherapy of Cancer|June 11, 2020
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric proteinNicolas Torres, María Victoria Regge, Florencia Secchiari, et al.
Pediatric Nephrology (Berlin, Germany)|November 11, 2024
Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndromeAlicia Fayad, Iliana Principi, Alejandro Balestracci, et al.
Revista Argentina De Microbiologia|June 10, 2023
Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in ArgentinaMarta Rivas, Mariana Pichel, Mariana Colonna, et al.
Global Change Biology|April 27, 2026
Invasive Fishes Interact With Temperature to Reshape Community Size Structure Across Climatic ZonesBarbbara Silva Rocha, Ignasi Arranz, Henrique C Giacomini, et al.
Plos One|September 26, 2022
Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort studyDiego H Farizano Salazar, Fernando Achinelli, Mariana Colonna, et al.
Pageof 54

Showing results (511-520 of 533) with videos related to

Sort By:
Pageof 54
Mbio|February 14, 2023
A Fijivirus Major Viroplasm Protein Shows RNA-Stimulated ATPase Activity by Adopting Pentameric and Hexameric Assemblies of DimersGabriela Llauger, Roberto Melero, Demián Monti, et al.
BMC Medical Education|October 12, 2018
The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countriesGoonaseelan Pillai, Kelly Chibale, Edwin C Constable, et al.
Translational Vision Science & Technology|August 21, 2020
Effects of Study Population, Labeling and Training on Glaucoma Detection Using Deep Learning AlgorithmsMark Christopher, Kenichi Nakahara, Christopher Bowd, et al.
Vaccine|December 26, 2006
Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccineEdda Sciutto, Gabriela Rosas, Marisela Hernández, et al.
Veterinary Immunology and Immunopathology|September 10, 2025
Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA YOLK) administered by parenteral or mucosal routes against Brucella ovis in ramsMaría Celeste Moran, Agostina Tammone Santos, Paula Dominguez, et al.
Journal for Immunotherapy of Cancer|June 11, 2020
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric proteinNicolas Torres, María Victoria Regge, Florencia Secchiari, et al.
Pediatric Nephrology (Berlin, Germany)|November 11, 2024
Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndromeAlicia Fayad, Iliana Principi, Alejandro Balestracci, et al.
Revista Argentina De Microbiologia|June 10, 2023
Surveillance of Shiga toxin-producing Escherichia coli associated bloody diarrhea in ArgentinaMarta Rivas, Mariana Pichel, Mariana Colonna, et al.
Global Change Biology|April 27, 2026
Invasive Fishes Interact With Temperature to Reshape Community Size Structure Across Climatic ZonesBarbbara Silva Rocha, Ignasi Arranz, Henrique C Giacomini, et al.
Plos One|September 26, 2022
Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort studyDiego H Farizano Salazar, Fernando Achinelli, Mariana Colonna, et al.
Pageof 54